Latest News - Danaher
Top Corporates Hub
Danaher
How Recent Developments Are Reframing The Danaher (DHR) Investment Story
18.02.2026 14:09
Why Danaher’s Price Target Just Nudged in the Other Direction Danaher’s fair value estimate has been reset slightly lower to about US$264.91 from roughly US$265.23, a small move that still keeps the stock’s modeled value in the mid US$260s. This fine tuning lines up with recent Street research, where several bullish analysts have clustered price targets in a similar range after updating their views on life science tools peers. If you care about how these small shifts can reshape the story...
Danaher’s $9.9B Masimo Deal Marks One of 2026’s Largest Medtech Buyouts
18.02.2026 13:50
Danaher (NYSE: DHR) is acquiring Masimo (NASDAQ: MASI) for $9.9 billion in an all-cash deal that values the medical technology company at $180 per share. The transaction, announced February 17, 2026, represents a nearly 40% premium over Masimo’s closing price on Friday, February 13, 2026. What Masimo Brings to the Table Masimo specializes in pulse ... Danaher’s $9.9B Masimo Deal Marks One of 2026’s Largest Medtech Buyouts
Masimo (MASI) Climbs 34% on $9.9-Billion Danaher Merger
18.02.2026 06:34
We recently published 10 Stocks Outperforming With Monstrous Gains. Masimo Corporation (NASDAQ:MASI) was one of the best performers on Tuesday. Masimo Corp. snapped a two-day losing streak on Tuesday, soaring 34.22 percent to finish at $174.69 apiece as investors snapped up shares following news that it was set to merge with Danaher Corp. for $9.9 […]
Discover the top S&P500 movers in Tuesday's pre-market session.
17.02.2026 13:35
Pre-market stock analysis of S&P500 stocks on 2026-02-17: top gainers and losers in today's session.
Danaher to buy Masimo in $9.9 billion deal
17.02.2026 13:07
Feb 17 () - Danaher will acquire pulse oximeter maker Masimo for $9.9 billion including debt, as the contract research firm looks to bulk up its diagnostics portfolio.
Masimo to be Acquired by Danaher for $180.00 Per Share
17.02.2026 13:02
IRVINE, Calif., February 17, 2026--Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) ("Danaher") will acquire Masimo for $180.00 per share in cash, representing a total consideration of $9.9 billion (the "Transaction").
Possible Bearish Signals With Danaher Insiders Disposing Stock
17.02.2026 13:00
The fact that multiple Danaher Corporation ( NYSE:DHR ) insiders offloaded a considerable amount of shares over the...
Danaher To Acquire Masimo Corporation
17.02.2026 13:00
Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $
Danaher Strikes $10 Billion Deal for Masimo
17.02.2026 11:09
The medical-device maker is expected to operate as a stand-alone company within Danaher’s Diagnostics segment.
Stocks to Watch Tuesday: Norwegian, Hyatt, Zim, Medtronic
17.02.2026 09:52
↗️ Norwegian Cruise Line (NCLH): Activist Elliott Investment Management has built a more than 10% stake in the cruise-ship operator and plans to push for changes to turn it around, The Wall Street Journal reported.
HIVE Digital Technologies, First Majestic Silver, Iamgold And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
17.02.2026 09:03
Masimo Stock Soars As Danaher Closes In On Blockbuster Deal
17.02.2026 06:46
Danaher approaches a $9.9 billion acquisition of Masimo following activist-led board changes and recent divestitures.
Why Danaher Corporation (NYSE:DHR) Could Be Worth Watching
13.02.2026 12:00
Let's talk about the popular Danaher Corporation ( NYSE:DHR ). The company's shares received a lot of attention from a...
Calculating The Fair Value Of Danaher Corporation (NYSE:DHR)
09.02.2026 12:00
Key Insights Danaher's estimated fair value is US$237 based on 2 Stage Free Cash Flow to Equity Current share price of...
A Look At Danaher (DHR) Valuation After Earnings And 2026 Targets Reaffirm Growth Story
05.02.2026 15:09
Danaher (DHR) is back in focus after its latest earnings, where revenue met Wall Street expectations and bioprocessing plus diagnostics helped support the outlook alongside new 2026 growth and profit targets. See our latest analysis for Danaher. Danaher shares have been choppy around the latest earnings release, with a recent 1 day share price return of 1.35% and a 30 day share price return showing a 6.73% decline, while the 1 year total shareholder return of 4.14% points to relatively modest...
Cleveland Diagnostics Names Jack Kenny as Chairman of the Board
05.02.2026 15:09
CLEVELAND, February 05, 2026--Cleveland Diagnostics Names Jack Kenny as Chairman of the Board
Exclusive: Lawhive, a startup using AI to reimagine the general practice law firm, raises $60 million in new venture capital funding
05.02.2026 08:00
The startup offers routine legal services using human lawyers assisted by AI software.
The Top 5 Analyst Questions From Danaher’s Q4 Earnings Call
04.02.2026 05:41
Danaher’s fourth quarter results met Wall Street’s revenue expectations, with management attributing performance to ongoing strength in its bioprocessing segment and steady growth in diagnostics. CEO Rainer Blair noted that bioprocessing consumables demand, especially for monoclonal antibodies, remained robust, while diagnostic platforms benefited from an active respiratory season and expanding test menus. However, management acknowledged ongoing softness in academic and government research fund
Danaher Invests In Automata To Deepen AI Driven Lab Workflows
31.01.2026 04:20
Danaher (NYSE:DHR) has entered an investment partnership with Automata, an AI ready lab automation company. The collaboration focuses on combining Automata's automation systems with Danaher's instruments, reagents, and software. The goal is to offer end to end, AI driven lab solutions that support faster scientific workflows and research. For you as an investor, this move sits at the intersection of life sciences and automation, two areas getting a lot of attention as labs look to scale...